BAS
NERV icon

Brown Advisory Securities’s Minerva Neurosciences NERV Stock Holding History

Brown Advisory Securities’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,369
Closed -$75K – 344
2018
Q4 		$75K Hold
1,369
– – 0.01% 344
2018
Q3 		$138K Hold
1,369
– – 0.02% 371
2018
Q2 		$90K Buy
+1,369
New +$83.1K 0.02% 373

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Brown Advisory Securities's NERV Position: Q1 2019 in Review

Brown Advisory Securities sold out of Minerva Neurosciences (NERV) in Q1 2019, closing a stake of 1,369 shares — an estimated $75K sold.

Brown Advisory Securities first reported a position in NERV in Q2 2018 and held it in 3 quarters. The position peaked at $138K in Q3 2018. 79 funds tracked by Wall St. Rank hold NERV as of Q1 2019.

  • Brown Advisory Securities reported no remaining Minerva Neurosciences position as of Q1 2019 after selling out during the quarter.
  • Brown Advisory Securities sold 1,369 Minerva Neurosciences shares in Q1 2019, an estimated $75K.
  • Brown Advisory Securities first reported a position in Minerva Neurosciences in Q2 2018 and held it in 3 quarters.
  • Brown Advisory Securities's Minerva Neurosciences position peaked at $138K in Q3 2018.
  • 79 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2019.

Based on Brown Advisory Securities's 13F filing for Q1 2019, filed 14 May 2019.